Day One Biopharmaceuticals, Inc. (DAWN) Earnings Report - Discounting Cash Flows
DAWN
Day One Biopharmaceuticals, Inc.
DAWN (NASDAQ)
Period Ending: 2026
02-24
2025
11-04
2025
08-05
2025
05-06
2025
02-25
2024
10-30
2024
07-30
2024
05-06
2024
02-26
2023
11-06
2023
08-07
2023
05-01
2023
03-06
2022
11-07
2022
08-04
2022
05-12
2022
03-07
2021
11-08
2021
08-10
2021
05-27
2021
03-30
2020
09-29
2020
06-29
2020
03-30
Actual EPS - -0.19 -0.29 -0.35 -0.69 0.38 -0.05 -0.72 -0.64 -0.54 -0.61 -0.59 -0.56 -0.53 -0.60 -0.48 -0.36 -0.33 -5.04 -0.56 -0.25 -0.05 -0.03 -0.02
Estimated EPS -0.15 -0.28 -0.35 -0.46 -0.35 -0.41 -0.67 -0.67 -0.57 -0.60 -0.60 -0.60 -0.57 -0.53 -0.49 -0.39 -0.36 -0.28 -0.31 - - - - -
Actual Revenue - 39.8 33.91 30.76 29.21 93.76 8.19 - 0.56 - - - - - - - - - - - - - - -
Estimated Revenue - 38.2 39.63 36.54 30.27 28.48 1.03 - - - - - - - - - - - - - - - - -
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program